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Experimental Approach

Introduction
• Metacaspases are enzymes involved in the cell death pathway of fungi. A
better understanding of metacaspase function can be helpful in the
development of the antifungal drugs.
• The final goal of the project is to elucidate the structures and the
properties of five types of metacaspase enzyme in the simple
multicellular S. commune fungus.
• The Fox Lab wants to study the properties of five types of metacaspase
in the S. commune fungus. In order to learn about this, we need to know
the structures of purified proteins. The Fox Lab has managed to clone all
five genes, among which, Scp 1, 2, and 3 have been expressed
successfully. Scp 1 and 3 have been purified.
• The Kehlbeck Lab is developing inhibitors for this S. commune
metacaspase. The project aims to produce compound 11 (Figure 1),
which is expected to serve as the inhibitor for all five metacaspases.

Figure 1. Berg’s Trypanosoma brucei
metacaspase inhibitor (TbMCA inhibitors #11)

Figure 2. Amino acid analogues in order to explore
the molecular features required for inhibition

Metacaspase Enzymes

H-NMR Analysis

• The synthesis of several amino acid benzothiazole analogues will confirm that Demkiw’s
synthesis pathway can be applied to our system to generate a library of potential inhibitors.
• These analogues will be evaluated for their ability to inhibit S. commune metacaspase
enzyme activity.
• Analogues with R groups with differing electronic and steric features will allow us to identify
the best inhibitors for S. commune metacaspase.

Metacaspase Inhibitor Synthesis

Figure 5. Two potential synthetic pathways for compound 11 as a potential inhibitor
for S. commune metacaspase represented by the synthesis mechanism for Berg’s
first hit T. brucei metacaspase inhibitor (above) and our proposed use of Demkiw’s
synthesis pathway from carboxylic acid and heteroaryl halides. (below)

Synthetic Routes

Figure 8. Comparison of H-NMR data of two starting materials 2-bromobenzothiazole (green) and ZAla-OH (red) and of the potential inhibitor product (blue) revealed the shift in benzene H and the
appearance of new peaks in the product H-NMR and confirmed the effectiveness of the proposed
synthesis pathway.

Conclusions and Future Plans

Figure 3. Trypanosoma brucei metacaspase (left)
and the zoom in view (right) of the binding site
where the inhibitor will bind to the enzyme and
block the activity of C213 and H158.

Benzothiazole synthesis

Figure 6. Synthesis of potential inhibitors for S.commune metacaspase
in order to analyze the effectiveness of the proposed synthesis
pathway and to study the inhibition activity on metacaspase.

R= -CH3

• Demkiw has developed a method that will allow us to explore the
molecular space of the benzothiazole. Different benzothiazole
compounds with different substituent groups on the benzene ring will
be used to generate different inhibitors.
• Therefore, the first part of the project is to create and scale up different
benzothiazole compounds as starting materials for the future synthesis
of a library of different inhibitors.

• From the promising H-NMR data, I aim to keep altering the synthesis
method gradually to gain a higher yield. The synthesis method will be
studied using different model reactions to compare how it works on
structures with different R-groups.
• The synthesized products from model reactions are then used to test the
activity of metacaspase enzyme in the Fox Lab.
• The final goal of the project is to make a library of different inhibitors for
S.commune metacaspase. The amended pathway will be applied to
make compound 11 and several different inhibitors with different Rgroups.
• Different potential inhibtors will be tested in order to propose the most
effective inhibitor for S.commune metacaspase.
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Figure 4. The synthesis of benzothiazole
from amine with different side groups
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Figure 7. Synthetic pathway for potential S. commune metacaspases inhibitors based on Demkiw’s systhesis method from
Carboxylic Acid and Heteroaryl Halides.
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